Share Dealing

Futura Medical PLC
07 July 2006


                                       
For Immediate Release                                        7 July 2006


                               Futura Medical Plc

                      Placing and Directors' Share Dealing



Futura Medical plc (AIM: FUM), the AIM-quoted pharmaceutical and medical device
group that develops innovative products for sexual health, is pleased to
announce that all resolutions at its annual general meeting held at 4pm on 6
July 2006 were passed unanimously.

In addition, the Company has entered into a placing agreement pursuant to which
Canaccord Adams Limited and Collins Stewart Limited have agreed to jointly place
up to 3,400,000 new ordinary shares at 78 pence per share ('the Placing Shares')
to raise £2.5 million after costs ('the Placing').

The Placing remains conditional, inter alia, on admission of the Placing Shares
to AIM, which the Company expects will occur on 10 July 2006.

In addition, Futura announces that the Directors set out in the table below have
now exercised options over 2,125,000 ordinary shares of 0.2 pence each in the
capital of Futura ('Ordinary Shares') in aggregate, and have agreed subsequently
to sell, conditional on Admission, at a price of 78 pence per share, 1,313,759
of the Ordinary Shares allotted in aggregate. In addition, certain staff have
exercised and agreed to sell, conditional upon Admission, options over 110,000
Ordinary Shares in aggregate, also at 78 pence per share. Therefore, the total
number of shares being sold on behalf of option holders will amount to 1,423,759
Ordinary Shares ('Sale Shares'). Full details of the arrangements are set out in
the table below.
   

Name       Position  Number of  Number    Sale      Directors' Directors'
                      options     of    price per    holding    holding
                     exercised  shares  share (in      pre        post
                                 sold    pence)      exercise   exercise

WD Potter  Chairman   375,000  293,902    78 p           Nil     81,098
JH Barder  CEO        250,000  183,285    78 p       551,497    618,212
DB Davies  Director  1,000,000 606,877    78 p        15,152    408,275
AL Clayden Director   500,000  229,695    78 p           Nil    270,305

     
(i)  JH Barder's holding includes shares beneficially owned and held by 
     connected parties.

(ii) The total proceeds to Futura from the intended exercise of the Directors 
     and staff options will amount to £ 831,250. Together with the net proceeds 
     of the Placing, Futura will receive £3.35 million.


James Barder, Futura's Chief Executive, said:

'I am delighted that the directors' holding in Futura has more than doubled.
This underlines the commitment we all have to the company and the prospects for
future growth.'



For further information:
Futura Medical plc
James Barder, Chief Executive                 Tel: [phone]
mailto:                                         www.futuramedical.co.uk
[e-mail]
Canaccord Adams Limited
Mark Ashurst                                  Tel: [phone]
Collins Stewart Limited
Philip Roe                                    Tel:+ 44 (0) 207 523 8323

Media enquiries:
Buchanan Communications
Mark Court / Rebecca Skye Dietrich            Tel: [phone]

www.futuramedical.co.uk





                      This information is provided by RNS
            The company news service from the London Stock Exchange